Search PubMed⌕ Search

Biomedical subjects

R Hernandez

Publications and source records attributed to R Hernandez.

196 records · Page 11Linked to original sources

Human interferon therapy for herpes zoster in adults.

Of 37 patients with herpes zoster 28 were treated with human exogenous interferon and 9 received only culture medium. The interferon was produced in leukocyte cultures and was given intramuscularly in one daily dose of 1 million units for 5-8 days. In the interferon-treated patients interferon was detectable in serum (peak level 1-5 hours after interferon injections) and in vesicle fluid, and in some patients also in urine samples. Anti-interferon antibodies were not found. Of the 28 interferon-treated patients 8 had a slight temperature increase and 4 showed a transient local reaction. In the interferon treated group of patients the duration of pain was shortened and the development of crust formation was enhanced compared with the control group.

Adolescent↗

Circulating interferon in man after administration of exogenous human leukocyte interferon.

Interferon was measured at different intervals after the iv, sc, and im application of exogenous human leukocyte interferon to patients with various virus diseases or neoplasms. Interferon injected iv into patients had a half-life of about 15 minutes in the 1st hour and of about 90 minutes in the next 3 hours. Six hours after iv injection of 30 million U, no serum interferon was detectable. With a continuous iv infusion, a relatively high serum interferon level was reached. By the im administration of 1 million U interferon, a peak level of serum interferon (mean value 107 U/ml serum) occurred after 2 hours and was fairly stable for about 6 hours. Twenty-four hours after im application, a low level of serum interferon was still detectable. Similar results were found after sc interferon injections. In a patient with subacute sclerosing panencephalitis, no interferon was found in the cerebrospinal fluid at the time of the highest serum interferon level and 24 hours after two im interferon injections. Only minimal side reactions resulted from sc and im interferon injections. In one patient, a shock reaction occurred after iv application. For therapeutic trials, about 1 million U exogenous human interferon should be injected twice daily im or sc.

Encephalitis↗

Separation of rubella IgM, IgA, and IgG antibodies by gel filtration on agarose.

Identification of the immunoglobulin classes of rubella antibodies is the only reliable tool for the diagnosis of a recent primary infection with rubella within 6-8 weeks of infection. Gel filtration permits the separation of IgM and IgA antibodies, both characteristic for a recent infection, from persistent rubella IgG antibody (which indicates pre-existing immunity). Gel filtration on agarose offers advantages over the other methods for separating immunoglobulin classes. Fractionation of specific rubella antibodies is important not only in all cases where a serum sample was taken too late and a rise of antibody titre missed, but also in cases with significant antibody rise to distinguish a secondary immune response after rubella reinfection.

Antibodies, Viral↗

[Experiments with simultaneous immunization against cytomegalovirus infection and rubella].

An immunisation trial with simultaneously applicated attenuated rubellavirus (Cendehill) and attenuated cytomegalovirus (TOWNE 125) was done in adults. There was no difference in antibody-titers against both viruses and in side-reactions (local ones only) between simultaneous or single application of the two viruses. Adults immunized against cytomegalovirus two years ago still had IF-IgG-antibodies; in only 1 of 8 volunteers there was a significant antibody-decline.

Antibodies, Viral↗

Regional not-for-profit systems: can they compete with national investor-owned firms?

The relative competitive advantages of regional and national systems are summarized in Figure One. As illustrated, each type of system has unique competitive advantages at the corporate level. While it is difficult to state that either system has distinct advantages that place it in a superior position relative to the other, it seems that in the short-run investor-owned systems have operating characteristics that may result in more efficient internal functioning because of more centralized control over resource allocation and performance systems, greater possibilities for economies of scale, and greater access to capital. However, it was previously noted that growing pressures from government and the business community will lead to tighter constraints on the profitability of investments in the health care sector. The possibility of this shift suggests that the access to capital advantage enjoyed by investor-owned systems may not continue. Additionally, regional systems that are part of larger affiliated organizations such as the Sun Alliance and the Voluntary Hospitals of America are developing means to pool their access to debt funds, thus reducing the cost of capital for member institutions. The group purchasing contracts developed by these large systems also have resulted in significant savings. The distinction between regional and national systems on centralized control are becoming less pronounced. Investor-owned systems are seeking to determine how they might best decentralize selected decisions to be more responsive to local markets while not-for-profit regional systems are recognizing that they must centralize selected decisions to obtain more efficient, rational operation. The long-run outlook suggests that the competitive advantages that have been identified will become less pronounced and that both systems will survive in the marketplace.

Economic Competition↗

[Population aging in Cuba].

"This article presents a brief discussion of the primary aspects associated with aging of the Cuban population, from a demographic, socioeconomic and political perspective. The first issue discussed in the article is how international immigration has contributed to the aging process of the country's population, and the possible causes of this immigration. The author...points out the efforts that the country is making to deal with an accelerated increase in the sixties-plus population...." (SUMMARY IN ENG)

Adult↗

Subcutaneous cyclosporin prevents the development of complete Freund's adjuvant-streptozotocin-induced diabetes in the rat.

The effect of subcutaneous cyclosporin administration (20 mg/kg) on the development of complete Freund's adjuvant (CFA)-streptozotocin-induced diabetes and on the induction of the so called cyclosporine diabetes like syndrome, were examined in Wistar rats. During and 5 weeks after the cyclosporin A treatment (21 days) the rats remained normoglycaemic. Three injections of 30 mg/kg streptozotocin given at weekly intervals, 24 hr after the administration of CFA, produced a persistent hyperglycaemia, an impairment of glucose tolerance and a drastic reduction in the pancreatic insulin content. The development of the diabetic state was prevented by cyclosporin treatment. The present results suggest that the cyclosporin diabetes like syndrome could not appear when cyclosporin was administered subcutaneously at the recommended doses for immunosuppression and that at such therapeutic doses, cyclosporin inhibits the development of CFA-Streptozotocin-induced diabetes in the Wistar rat.

Animals↗

Idiopathic hypercalciuria: effects of calcium load test on magnesiuria.

Twenty-three children with idiopathic hypercalciuria and 7 control children were studied. Patients were classified into three groups according to the response to an oral calcium load. Five children displayed absorptive hypercalciuria (UCa/Cr 0.14 +/- 0.04 mg/mg with poor calcium diet and 0.33 +/- 0.16 after loading, p less than 0.01); 10 were classified renal hypercalciuria (UCa/Cr during the fasting state of 0.28 +/- 0.09 and 0.31 +/- 0.11 after loading) and 8 were classified as alimentary hypercalciuria (UCa/Cr 0.14 +/- 0.07 during the fasting state and 0.15 +/- 0.04 after loading). The urinary cAMP showed no significant differences in any of the three groups compared to the control. Magnesiuria did not show significant differences between the two forms of hypercalciuria and the control; a significant increase was observed after the loading and a positive correlation between magnesiuria and calciuria in the absorptive form. Our study supports the validity of the test for the classification of the different forms of hypercalciuria in children. The urinary cAMP is not a valid approach for classification. The difference observed in the magnesiuria suggests a different pathogenic mechanism between the two types of idiopathic hypercalciuria.

Administration, Oral↗